GoldenGolden
Syros Pharmaceuticals

Syros Pharmaceuticals

A company focused on mapping and controlling the genes to treat diseases

Syros Pharmaceuticals is a biopharmaceutical company that specializes in developing treatments for cancer and immune-mediated diseases, as well as building a pipeline of gene control medicines.

Timeline

January 2021
Syros Pharmaceuticals raises a $75,600,000 venture round.
December 2020
Syros Pharmaceuticals raises a $90,500,000 venture round from Ally Bridge Group, Bain Capital, Bain Capital Life Sciences, EcoR1 Capital, Omega Funds, OrbiMed and Samsara BioCapital.
February 2020
Syros Pharmaceuticals raises a $60,000,000 venture round from Oxford Finance Llc.
February 2018
Syros Pharmaceuticals raises a $11,400,000 venture round.
April 2017
Syros Pharmaceuticals raises a $35,000,000 venture round.
January 2016
Syros Pharmaceuticals raises a $40,000,000 series C round from Aisling Capital, Alexandria Venture Investments, Casdin Capital, Deerfield Management Company, Fidelity Management & Research Company, Polaris Partners, Redmile Group and WuXi Healthcare Ventures.
October 2014
Syros Pharmaceuticals raises a $53,000,000 series B round from ARCH Venture Partners, Aisling Capital, Alexandria Venture Investments, Flagship Pioneering, Polaris Partners, Redmile Group and WuXi Healthcare Ventures.
April 11, 2013
Syros Pharmaceuticals raises a $30,000,000 series A round from ARCH Venture Partners and Flagship Pioneering.
2011
Syros Pharmaceuticals was founded by Alexander Rives, James E. Bradner, Nathanael Gray and Richard Young.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Syros Pharmaceuticals Series C round, January 2016
40,000,000
January 2016
12 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Alexander Rives

Founder

Fay Xing

Investor

Katherine Chanthavong

Employee

Sarah Knutson

Employee

Shamini Thiagarajan

Employee

Sofija Miljovska

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.